Observational studyAmerican journal of hematology2026
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.
Gaspar Aspas Requena et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.